Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NexgenRx Inc V.NXG

Alternate Symbol(s):  NEGXF

NexgenRx Inc. is a Canada-based third-party administrator and technology solutions provider. The Company is focused on building technology platforms that equip its clients with unprecedented capabilities for managing and self-managing group benefit plans, group pension plans and patient support programs. The Company offers plan sponsors, administration and health benefit technology applications... see more

TSXV:NXG - Post Discussion

NexgenRx Inc > Interesting market action
View:
Post by AuAgLi8 on Oct 09, 2021 7:03am

Interesting market action

- Volume multifold from benchmark on October 8/2021.
-Looks like someone is intrigued with NexgenRX.
-This under the radar company deserves watching.
-Tightly held by long term investors .
-Strong management.
-Uniquely positioned and Independent.
-Increasing EBIDTA.
-Little debt.
-$25 million Canadian market cap.

-Poised for explosive growth.

-Draw Your Own conclusions.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities